Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis
Journal of Controlled Release · 2026-11 · 399 · 115359
DOI: 10.1016/j.jconrel.2026.115359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Prabhat Shrestha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Catechin, Colon, Anti-Inflammatory Agents. Die Arbeit nennt 111 Literaturangaben. Gefördert von: Rural Development Administration, National Research Foundation of Korea.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic intestinal inflammatory disorder characterized by epithelial barrier disruption, oxidative stress, and gut microbiota dysbiosis. Although epigallocatechin-3-gallate (EGCG) exhibits potent anti-inflammatory and antioxidant activities, its clinical application is limited by poor stability and low colonic bioavailability. Herein, EGCG-loaded Eudragit® S100-coated chitosan microparticles (EG@euCS MPs) were developed as a colon-targeted oral delivery platforms integrating mucoadhesive retention with pH-responsive release. EG@euCS MPs effectively protected EGCG during gastrointestinal transit and achieved sustained release under colonic conditions. In vitro, EG@euCS MPs enhanced cellular uptake, reduced oxidative stress, promoted anti-inflammatory macrophage polarization, and restored epithelial barrier integrity. In a dextran sulfate sodium (DSS)-induced colitis mice, EG@euCS MPs achieved prolonged colonic retention and significantly alleviated disease severity, as evidenced by improved clinical symptoms, reduced inflammatory responses, restored colon morphology, and enhanced tight junction expression. Importantly, integrated 16S rRNA sequencing, short-chain fatty acid profiling, and untargeted metabolomics revealed that EG@euCS MPs restored microbial and metabolic homeostasis, characterized by enrichment of beneficial taxa, including Akkermansia, increased acetate, propionate, and butyrate production, recovery of antioxidant and tryptophan-related metabolites, and attenuation of inflammatory lipid mediators. Collectively, EG@euCS MPs coordinate the regulation of inflammatory, microbial, and metabolic pathways, representing promising colon targeted therapeutics for UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
- College of Sport Science, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: khkim83@skku.edu.
- Department of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon 16419, Republic of Korea; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address: ysimmyung@skku.edu.
Förderung
- Rural Development Administration
- National Research Foundation of Korea
Zitieren
APA
Shrestha, P., Park, J., Jeong, S. Y., Jang, Y. S., Yoo, S., Lee, H. J., Kwon, T. K., Cho, J., Kim, K. H., & Yook, S. (2026). Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis. Journal of Controlled Release, 399, 115359. https://doi.org/10.1016/j.jconrel.2026.115359
Vancouver
Shrestha P, Park J, Jeong SY, Jang YS, Yoo S, Lee HJ, et al. Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis. Journal of Controlled Release. 2026;399:115359. doi:10.1016/j.jconrel.2026.115359
BibTeX
@article{Shrestha2026,
author = {Shrestha, Prabhat and Park, Jongjun and Jeong, Se Yun and Jang, Yoon Seo and Yoo, Seungchan and Lee, Hyo-Jong and Kwon, Taeg Kyu and Cho, Jinkyung and Kim, Ki Hyun and Yook, Simmyung},
title = {Colon-targeted EGCG delivery remodels the gut microenvironment to enhance therapeutic efficacy in ulcerative colitis},
journal = {Journal of Controlled Release},
year = {2026},
volume = {399},
pages = {115359},
doi = {10.1016/j.jconrel.2026.115359}
}
EUVIMED